Legend Biotech (LEGN) said Tuesday Janssen Biotech has reported $369 million in net trade sales for Legend's Carvykti cancer treatment in the quarter ended March 31.
Shares of the company were up about 7.9% in recent trading.
Price: 34.66, Change: +2.55, Percent Change: +7.94